SoftOx Solutions AS Share Price Oslo Bors
Equities
NO0010811961
Biotechnology & Medical Research
Sales 2021 | 7.9M 735K 58.24M | Sales 2022 | 7.11M 661K 52.44M | Capitalization | 241M 22.41M 1.78B |
---|---|---|---|---|---|
Net income 2021 | -65M -6.04M -479M | Net income 2022 | -71M -6.6M -523M | EV / Sales 2021 | 64.3 x |
Net cash position 2021 | 56.98M 5.3M 420M | Net cash position 2022 | 6.91M 642K 50.91M | EV / Sales 2022 | 32.9 x |
P/E ratio 2021 |
-8.86
x | P/E ratio 2022 |
-3.39
x | Employees | - |
Yield 2021 * |
-
| Yield 2022 |
-
| Free-Float | 96.54% |
Latest transcript on SoftOx Solutions AS
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | - | - | |
Geir Almås
FOU | Founder | - | 20/06/12 |
Harald Sætvedt
DFI | Director of Finance/CFO | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Olav Jarlsby
BRD | Director/Board Member | - | 16/04/15 |
Geir Almås
FOU | Founder | - | 20/06/12 |
Adrian Bignami
BRD | Director/Board Member | - | - |
1st Jan change | Capi. | |
---|---|---|
+5.33% | 111B | |
+12.11% | 106B | |
-12.56% | 22.24B | |
-3.64% | 21.25B | |
-5.94% | 18.97B | |
-35.21% | 18.52B | |
-10.86% | 16.81B | |
+37.57% | 12.54B | |
-26.24% | 8.09B |